Company / Operating Cash Flow per Share
Verrica Pharmaceuticals Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$6.64
FY2025
5-year range
-$6.64 / -$0.45
FY2021-FY2025
Trend
-629.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -630% YoY in FY2025, a notable deviation from the 4-year average annual change of -165%.
Based on SEC 10-K filings.
-6.64 in FY2025.
Declined from $-0.45 to $-6.64 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 629.9% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.64 | -629.9% |
| FY2024 | -$0.91 | -100.4% |
| FY2023 | -$0.45 | +54.7% |
| FY2022 | -$1.00 | +15.6% |
| FY2021 | -$1.19 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026